ALB and hepatocellular carcinoma: Multivariable analysis indicated that the risk factors for overall survival were serum albumin ≤3.5 g/dL (HR 1.58 with 95% CI: 1.05–2.38, p = 0.027), BCLC stage B (HR 2.07 with 95% CI: 1.21–3.54, p = 0.008), BCLC stage C (HR 3.96 with 95% CI: 2.28–6.87, p<0.001), bilobar location of HCC (HR 1.66 with 95% CI: 1.08–2.55, p = 0.022), AKI stage 1 (HR 6.09 with 95% CI: 3.68–19.67, p<0.001), AKI stage 2 (HR 8.51 with 95% CI: 2.54–14.57, p<0.001) and AKI stage 3 (HR 17.64 with 95% CI: 8.23–37.82, p<0.001).